JuSER 27 records found  1 - 10nextend  jump to record: Search took 0.00 seconds. 
1.
OpenAccess [FZJ-2025-02236] Journal Article
; ; ; et al
Functional connectivity between tumor region and resting-state networks as imaging biomarker for overall survival in recurrent gliomas diagnosed by O -(2-[18F]fluoroethyl)- l -tyrosine PET
BackgroundAmino acid PET using the tracer O-(2-[18F]fluoroethyl)-l-tyrosine (FET) is one of the most reliable imaging methods for detecting glioma recurrence. Here, we hypothesized that functional MR connectivity between the metabolic active recurrent tumor region and resting-state networks of the brain could serve as a prognostic imaging biomarker for overall survival (OS).MethodsThe study included 82 patients (26–81 years; median Eastern Cooperative Oncology Group performance score, 0) with recurrent gliomas following therapy (WHO-CNS 2021 grade 4 glioblastoma, n = 57; grade 3 or 4 astrocytoma, n = 12; grade 2 or 3 oligodendroglioma, n = 13) diagnosed by FET PET simultaneously acquired with functional resting-state MR. [...]
OpenAccess: Download fulltextPDF (additional files);
2.
3.
[FZJ-2024-02773] Abstract
; ; ; et al
P01.02.A WHOLE-BRAIN STRUCTURAL CONNECTIVITY PREDICTS COGNITIVE OUTCOMES IN PRETREATED PATIENTS WITH WHO GRADE 3 OR 4 GLIOMAS
18th Meeting of the European Association of Neuro-Oncology, RotterdamRotterdam, Netherlands, 21 Sep 2023 - 24 Sep 20232023-09-212023-09-24 () [10.1093/neuonc/noad137.076]
BACKGROUNDGlioma patients frequently suffer from cognitive dysfunction potentially related to brain damage caused by tumor invasion or therapeutic intervention. We hypothesized that, as in other neurological disorders, the long-term outcome of cognitive functions in glioma patients critically depends on maintaining the structural connectivity of multiple interconnected networks.PATIENTS AND METHODSOne hundred and twenty-one glioma patients (median age, 52 years; median ECOG score, 1) with histomolecularly characterized CNS WHO grade 3 or 4 gliomas were investigated after a median time of 14 months (range, 1-214 months) following first-line therapy, including resection and chemoradiation with alkylating agents. [...]
4.
OpenAccess [FZJ-2023-04494] Journal Article
; ; ; et al
Structural connectome-based predictive modeling of cognitive deficits in treated glioma patients
AbstractBackground. In glioma patients, tumor growth and subsequent treatments are associated with various types ofbrain lesions. [...]
OpenAccess: Download fulltextPDF (additional files);
5.
6.
7.
OpenAccess [FZJ-2023-00223] Journal Article
; ; ; et al
Clinical applications and prospects of PET imaging in patients with IDH-mutant gliomas
PET imaging using radiolabeled amino acids in addition to MRI has become a valuable diagnostic tool in the clinical management of patients with brain tumors. This review provides a comprehensive overview of PET studies in glioma patients with a mutation in the isocitrate dehydrogenase gene (IDH). [...]
OpenAccess: Download fulltextPDF;
8.
9.
10.
OpenAccess [FZJ-2022-02703] Journal Article
; ; ; et al
Two Decades of Brain Tumour Imaging with O-(2-[18F]fluoroethyl)-L-tyrosine PET: The Forschungszentrum Jülich Experience
Cancers 14(14), 3336 - () [10.3390/cancers14143336]
PET using radiolabelled amino acids has become an essential tool for diagnosing brain tumours in addition to MRI. O-(2-[18F]fluoroethyl)-L-tyrosine (FET) is one of the most successful tracers in the field [...]
OpenAccess: Download fulltextPDF;

JuSER : 27 records found   1 - 10nextend  jump to record:
Interested in being notified about new results for this query?
Subscribe to the RSS feed.